MLchartDataset catalogue

recombinant human thrombopoietin

Term · Oncology and biomedicine · MLC-T-ONC-016427

A recombinantly produced form of human thrombopoietin (rHuTPO). rHuTPO stimulates platelet formation and has potential use as a therapeutic agent to prevent thrombocytopenia in patients receiving chemotherapy.

Table 1. Record
IdentifierMLC-T-ONC-016427
FieldOncology and biomedicine
AbbreviationrHuTPO
Synonymsrecombinant human TPO; megakaryocyte growth and development factor
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-016427",
  "term": "recombinant human thrombopoietin",
  "field": "Oncology and biomedicine",
  "definition": "A recombinantly produced form of human thrombopoietin (rHuTPO). rHuTPO stimulates platelet formation and has potential use as a therapeutic agent to prevent thrombocytopenia in patients receiving chemotherapy.",
  "abbreviation": "rHuTPO",
  "synonyms": [
    "recombinant human TPO",
    "megakaryocyte growth and development factor"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/recombinant-human-thrombopoietin/"
}

Record 14,176 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.